CNS‐active drugs for neuropsychiatric disorders differentially modulate the risk of AD development
用于治疗神经精神疾病的中枢神经系统活性药物对阿尔茨海默病(AD)的发生风险具有不同的调节作用。
期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.abh1314
Cai, Song; Moutal, Aubin; Yu, Jie; Chew, Lindsey A; Isensee, Jörg; Chawla, Reena; Gomez, Kimberly; Luo, Shizhen; Zhou, Yuan; Chefdeville, Aude; Madura, Cynthia; Perez-Miller, Samantha; Bellampalli, Shreya Sai; Dorame, Angie; Scott, David D; François-Moutal, Liberty; Shan, Zhiming; Woodward, Taylor; Gokhale, Vijay; Hohmann, Andrea G; Vanderah, Todd W; Patek, Marcel; Khanna, May; Hucho, Tim; Khanna, Rajesh; Cortes‐Flores, Helena; Torrandell‐Haro, Georgina; Brinton, Roberta Diaz